OGN
Organon & Co. Healthcare - Drug Manufacturers - General Investor Relations →
Organon & Co. (OGN) closed at $13.43 as of 2026-06-19, trading 12.6% below its 200-week moving average of $15.37. This places OGN in the extreme value zone. The stock moved further from the line this week, up from -12.9% last week. With a 14-week RSI of 93, OGN is in overbought territory.
Trading activity has gone quiet — just 0.4x of its usual 14-week average. But the buying that is happening outweighs the selling (2.92 buyers-vs-sellers ratio). When volume dries up but buyers are still showing up more than sellers, it can mean the worst of the selling is over and the stock is quietly building a floor.
Over the past 218 weeks of data, OGN has crossed below its 200-week moving average 3 times. On average, these episodes lasted 69 weeks. The average one-year return after crossing below was -29.0%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $3.5 billion, OGN is a mid-cap stock. The company generates a free cash flow yield of 15.0%, which is notably high. Return on equity stands at 34.0%, indicating strong profitability. The stock trades at 3.9x book value.
Share count has increased 2.3% over three years, indicating dilution.
Over the past 4.2 years, a hypothetical investment of $100 in OGN would have grown to $50, compared to $192 for the S&P 500. OGN has returned -15.2% annualized vs 16.6% for the index, underperforming the broader market over this period.
In the past 12 months, corporate insiders have made 2 open-market purchases totaling $854,835. Notably, these purchases occurred while OGN is trading below its 200-week moving average — insiders are buying when the market is most pessimistic.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: OGN vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After OGN Crosses Below the Line?
Across 3 historical episodes, buying OGN when it crossed below its 200-week moving average produced an average return of -30.3% after 12 months (median -29.0%), compared to +12.3% for the S&P 500 over the same periods. After 24 months, the average return was -33.3% vs +38.7% for the index.
Each line shows $100 invested at the moment OGN crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Bean Score Experimental
The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices OGN would reach each dislocation threshold.
Dislocation Price Levels
Prices where OGN's Bean Score would hit each σ threshold. Valid until next earnings report (date TBD — last report: 2026-03-31).
| Level | σ | Price | Signal |
|---|---|---|---|
| Deep Value | +2σ | $4.91 | Unusually cheap — potential buy zone |
| Value | +1σ | $6.05 | Cheap vs. own history |
| Fair Value | +0σ | $7.89 | Historical mean behavior |
| Expensive | -1σ | $11.30 | Expensive vs. own history |
| Deep Expensive | -2σ | $19.95 | Unusually expensive — potential trim zone |
Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end
Signal Accuracy Collecting Data
The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"
Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.
Dislocation Scores Experimental
Each score measures deviation from OGN's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.
Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.
Historical Touches
OGN has crossed below its 200-week MA 3 times with an average 1-year return of +-29.0% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Apr 2022 | May 2022 | 2 | 1.1% | -22.3% | -50.2% |
| Jul 2022 | Jan 2023 | 27 | 27.0% | -35.8% | -51.3% |
| Jan 2023 | Ongoing | 178+ | 64.3% | Ongoing | -47.8% |
| Average | 69 | — | +-29.0% | — |
Frequently Asked Questions
Is OGN below its 200-week moving average?
Yes. As of 2026-06-19, Organon & Co. (OGN) is trading 12.6% below its 200-week moving average of $15.37. The current price is $13.43.
What is OGN's 200-week moving average price?
Organon & Co.'s 200-week moving average is $15.37 as of 2026-06-19. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when OGN drops below its 200-week moving average?
OGN has crossed below its 200-week moving average 3 times in our data. The average one-year return after these crossings was -29.0%, meaning the dips were not reliable buying signals for this particular stock. These episodes lasted 69 weeks on average.
Is OGN a good value right now?
Here's what our data says about OGN as of 2026-06-19: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 93 (overbought). Free cash flow yield is 15.0%. Return on equity is 34.0%. Price-to-book is 3.9x. This is not a buy or sell recommendation — always do your own research.
How does OGN compare to the S&P 500?
Over the past 4.2 years, $100 invested in OGN would have grown to $50, compared to $192 for the S&P 500. That's -15.2% annualized vs 16.6% for the index. OGN has underperformed the broader market over this period.
Does OGN pay a dividend?
Yes. Organon & Co. currently pays a dividend yield of 60.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-06-19